BofA Strategists See More Pain in Store Before Stocks Reach Low

image

(Bloomberg) — Stock markets and the US economy will have to experience more pain before the Federal Reserve pivots away from its aggressive policy tightening, according to Bank of America Corp. strategists.

Thursday’s rally in US stocks after a hot inflation print resembled a “bear hug” amid oversold conditions, high cash levels and the lack of a credit event, strategists led by Michael Harnett wrote in a note. The development was the latest in a volatile year marked by fears of a recession with the Fed unbending in its resolve to bring prices under control.

It was a “decent counter-rally,” but lows won’t be reached until 2023, the strategists wrote. More economic and market pain will be necessary before the Fed backs down, they said.

Separately, Barclays Plc strategist Emmanuel Cau said Friday that defensive positioning and “uber bearish sentiment” can help stocks to bounce from oversold levels, but that “growth and policy fundamentals continue to argue against a sustained rally.”

According to the BofA strategists, the best contrarian trades once stocks hit their lows next year will be shorting the US dollar and going long a portfolio with 60% of its holdings in equities and 40% in bonds. The bank’s custom bull-and-bear indicator remains at the “maximum bearish” level, often regarded as a contrarian buy signal.

Global equity funds saw about $300 million of inflows in the week through Oct. 12, the bank said in the note, citing EPFR Global data which was compiled prior to Thursday’s US inflation report. Cash had inflows of $100 million, while $9.8 billion was pulled from bonds and gold saw redemptions of $300 million.

In the US, equity funds had $5.2 billion of inflows in the most recent week, while those in Europe posted outflows for a 35th straight week, BofA said.

By trading style, investors poured cash into US large caps, value and growth. Among sectors, tech had the largest inflows at $1 billion while consumer stocks had the largest redemptions at $800 million.

©2022 Bloomberg L.P.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More